How many employees work at Minapharm Pharmaceuticals?
Minapharm Pharmaceuticals (MIPH) has approximately 1,498 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Minapharm Pharmaceuticals's total headcount has grown 10.0% from 1,361 employees in 2023 to 1,498 in 2026.
Data source: Revelio LabsCoverage: Global workforce, 2023–2026Published July 2026
Is Minapharm Pharmaceuticals hiring right now?
Yes, Minapharm Pharmaceuticals is actively hiring. Minapharm Pharmaceuticals had 55 active job postings in 2026, a 65.1% increase from 2025 — see job openings & hiring trends.
About Minapharm Pharmaceuticals's Workforce
Minapharm Pharmaceuticals (MIPH) is a Pharmaceuticals company that employs 1,498 people worldwide as of March 2026. It is the 10th-largest by headcount among its peers. Founded in 1958, the company is headquartered in Cairo, Egypt and trades on the Egyptian Exchange.
Minapharm Pharmaceuticals's workforce has grown 10.0% from 2023 to 2026, up 7.6% year over year in 2026. Its workforce is concentrated most in Egypt (79.0%), followed by Germany (19.3%) and Tanzania (0.6%), with Germany, its fastest-growing location, up 10.0%.
Minapharm Pharmaceuticals's largest functional groups are Finance and Operations (47.7%), Sales and Marketing (26.3%), and Engineering (26.1%), with Engineering growing fastest (up 6.4%). Median employee tenure is 4.3 years. The average salary is $24,178, ranging from a median of $71,000 in Western Europe to $5,000 in Sub-Saharan Africa.
Minapharm Pharmaceuticals's active job postings rose 65.1% in 2026 to 55, with new postings per month cooling from 32 in 2023 to 26 in 2026. Overall employee sentiment is positive and broadly stable.
Sourced from Revelio Labs workforce data.
As of March 2026
Minapharm Pharmaceuticals
workforce metrics
Headcount
1.5k
7.6% YoY
Avg. Salary
$24.2k
3.3% YoY
Tenure
4.3yr
0.6yr YoY
Growth Rate
7.6%
8.1pts YoY
Hiring Rate
Attrition Rate
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Minapharm Pharmaceuticals. Compare to peers, export the dataset, and access the full quarterly history.
- Minapharm Pharmaceuticals had 1,498 employees in 2026, a 7.6% increase (+110) from 2025.
- Minapharm Pharmaceuticals had 1,438 employees in 2025, a 3.1% increase (+43) from 2024.
- Minapharm Pharmaceuticals had 1,395 employees in 2024, a 0.9% decline (-12) from 2023.
- Minapharm Pharmaceuticals had 1,407 employees in 2023, a 9.7% increase (+131) from 2022.
Minapharm Pharmaceuticals's total workforce has grown from 1,361 employees in 2023 to 1,498 in 2026.
Minapharm Pharmaceuticals — quarterly employee count (2023–2026)
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 1,498 | +110 | +7.6% |
| 2025 | Q4 | 1,438 | +43 | +3.1% |
| 2025 | Q3 | 1,455 | +74 | +5.2% |
| 2025 | Q2 | 1,386 | +14 | +1.0% |
| 2025 | Q1 | 1,388 | -6 | -0.4% |
| 2024 | Q4 | 1,395 | -12 | -0.9% |
| 2024 | Q3 | 1,381 | -33 | -2.3% |
| 2024 | Q2 | 1,372 | +11 | +0.8% |
| 2024 | Q1 | 1,394 | +89 | +6.6% |
| 2023 | Q4 | 1,407 | +131 | +9.7% |
| 2023 | Q3 | 1,414 | +195 | +14.8% |
| 2023 | Q2 | 1,361 | +165 | +12.9% |
Want to see Minapharm Pharmaceuticals's complete headcount history back to 2008, including quarterly breakdowns?
Egypt accounts for the largest share of Minapharm Pharmaceuticals's global workforce with approximately 79% of total employees, followed by Germany and Tanzania. Minapharm Pharmaceuticals's headcount in Germany is growing fastest among its major locations, up 10.0% year over year in 2026.
Minapharm Pharmaceuticals employees by country — 2026
| Country | Employees | % of Total | YoY % |
|---|---|---|---|
| Egypt | 1,191 | 79.0% | +5.2% |
| Germany | 291 | 19.3% | +10.0% |
| Tanzania | 8 | 0.6% | +0.0% |
| South Africa | 4 | 0.3% | +0.0% |
| United States | 3 | 0.2% | +0.0% |
| United Arab Emirates | 3 | 0.2% | -35.2% |
| Mexico | 2 | 0.1% | +0.0% |
| Morocco | 2 | 0.1% | +0.0% |
| Saudi Arabia | 1 | 0.1% | +0.0% |
| Iran | 1 | 0.1% | +0.0% |
Drill into city-level data, hiring trends by region and historic geographic shifts
Minapharm Pharmaceuticals's largest employee groups are Finance and Operations (47.7%), Sales and Marketing (26.3%), and Engineering (26.1%).
Minapharm Pharmaceuticals employees by department — 2026
| Department | Employees | % of Total | YoY % |
|---|---|---|---|
| Finance and Operations | 718 | 47.7% | +4.1% |
| Sales and Marketing | 396 | 26.3% | +6.3% |
| Engineering | 393 | 26.1% | +6.4% |
Compare Minapharm Pharmaceuticals's department mix to industry peers.
Minapharm Pharmaceuticals's average employee salary is $24,178 globally. Employees in Western Europe receive the highest compensation, with median pay approximately 2.9x the global average. Pay is lowest in Sub-Saharan Africa, at a median of $5,000.
Minapharm Pharmaceuticals median employee salary by region — 2026 (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $71,000 |
| Arab States | $53,000 |
| Northern Africa | $7,000 |
| Sub-Saharan Africa | $5,000 |
Unlock salary by role, level, and city — and compare to Minapharm Pharmaceuticals's industry peers.
- Minapharm Pharmaceuticals had 55 active job postings in 2026, a 65.1% increase from 2025.
- Minapharm Pharmaceuticals had 55 active job postings in 2025, a 47.2% increase (+21) from 2024.
- Minapharm Pharmaceuticals had 34 active job postings in 2024, a 95.7% increase (+22) from 2023.
- Minapharm Pharmaceuticals had 12 active job postings in 2023, a 73.7% decline from 2022.
- Hiring velocity in 2026: 26 new roles/month, down from 28 in 2025 and 29 in 2024. New metric
Minapharm Pharmaceuticals's active job postings rose 65.1% in 2026 to 55, with new postings per month cooling from 32 in 2023 to 26 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Revelio Labs tracks employee sentiment across Minapharm Pharmaceuticals's workforce based on public professional data. Overall sentiment is positive and has held steady year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.